Arafat Nasser
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Arafat Nasser has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Clara Aabye Madsen
Neurobiology Research Unit, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
2 shared publications - Gitte Moos Knudsen
Neurobiology Research Unit, Rigshospitalet, Copenhagen, Denmark
2 shared publications - Hanne Demant Hansen
Neurobiology Research Unit and NeuroPharm, Department of Neurology, Rigshospitalet, Copenhagen, Denmark
2 shared publications - Nakul Ravi Raval
Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, USA
2 shared publications - Pontus Plavén-Sigray
Neurobiology Research Unit, Copenhagen University Hospital, Copenhagen, Denmark
2 shared publications - Adriaan A. Lammertsma
University Medical Center Groningen, University of Groningen
1 shared publication
Latest Publications
- Open Access
Kinetic models for PET displacement studies
The traditional design of PET target engagement studies is based on a baseline scan and one or more scans after drug administration. We here evaluate an alternative design in which the drug is administered during an on-going scan (i.e., a displacement study). This approach results both in lower radiation exposure and lower costs. Existing kinetic models assume steady state. This condition is not present during a drug displacement and consequently, our aim here was to develop kinetic models for analysing PET displacement data. We modified existing compartment models to accommodate a time-variant increase in occupancy following the pharmacological in-scan intervention. Since this implies the use of differential equations that cannot be solved analytically, we developed instead one approximate and one numerical solution. Through simulations, we show that if the occupancy is relatively high, it can be estimated without bias and with good accuracy. The models were applied to PET data from six pigs where [ 11 C]UCB-J was displaced by intravenous brivaracetam. The dose-occupancy relationship estimated from these scans showed good agreement with occupancies calculated with Lassen plot applied to baseline-block scans of two pigs. In summary, the proposed models provide a framework to determine target occupancy from a single displacement scan.
Open AccessKinetic models for PET displacement studies
The traditional design of PET target engagement studies is based on a baseline scan and one or more scans after drug administration. We here evaluate an alternative design in which the drug is administered during an on-going scan (i.e., a displacement study). This approach results both in lower radiation exposure and lower costs. Existing kinetic models assume steady state. This condition is not present during a drug displacement and consequently, our aim here was to develop kinetic models for analysing PET displacement data. We modified existing compartment models to accommodate a time-variant increase in occupancy following the pharmacological in-scan intervention. Since this implies the use of differential equations that cannot be solved analytically, we developed instead one approximate and one numerical solution. Through simulations, we show that if the occupancy is relatively high, it can be estimated without bias and with good accuracy. The models were applied to PET data from six pigs where [ 11 C]UCB-J was displaced by intravenous brivaracetam. The dose-occupancy relationship estimated from these scans showed good agreement with occupancies calculated with Lassen plot applied to baseline-block scans of two pigs. In summary, the proposed models provide a framework to determine target occupancy from a single displacement scan.
- Open Access
Evaluation of the α-synuclein PET radiotracer (d 3 )-[ 11 C]MODAG-001 in pigs
Background: A positron emission tomography (PET) radiotracer to neuroimage α-synuclein aggregates would be a crucial addition for early diagnosis and treatment development in disorders such as Parkinson’s disease, where elevated aggregate levels is a histopathological hallmark. The radiotracer (d 3 )-[ 11 C]MODAG-001 has recently shown promise for visualization of α-synuclein pre-formed fibrils (α-PFF) in rodents. We here test the radiotracer in a pig model where proteins are intracerebrally injected immediately before scanning. Four pigs were injected in one hemisphere with 150 µg α-PFF, and in the other hemisphere, either 75 µg α-PFF or human brain homogenate from either dementia with Lewy bodies (DLB) or Alzheimer’s disease (AD) was injected. All pigs underwent one or two (d 3 )-[ 11 C]MODAG-001 PET scans, quantified with the non-invasive Logan graphical analysis using the occipital cortex as a reference region. Results: The α-PFF and AD homogenate injected brain regions had high uptake of (d 3 )-[ 11 C]MODAG-001 compared to the occipital cortex or cerebellum. BP ND values in 150 µg α-PFF injected regions was 0.78, and in the AD homogenate injected regions was 0.73. By contrast, the DLB homogenate injected region did not differ in uptake and clearance compared to the reference regions. The time-activity curves and BP ND values in the 150 µg and 75 µg injected region of α-PFFs show a dose-dependent effect, and the PET signal could be blocked by pretreatment with unlabeled MODAG-001. Conclusion: We find that both α-PFF and AD brain homogenates give rise to increased binding of (d 3 )-[ 11 C]MODAG-001 when injected into the pig brain. Despite its limited specificity for cerebral α-synuclein pathology, (d 3 )-[ 11 C]MODAG-001 shows promise as a lead tracer for future radiotracer development.
Open AccessEvaluation of the α-synuclein PET radiotracer (d 3 )-[ 11 C]MODAG-001 in pigs
Background: A positron emission tomography (PET) radiotracer to neuroimage α-synuclein aggregates would be a crucial addition for early diagnosis and treatment development in disorders such as Parkinson’s disease, where elevated aggregate levels is a histopathological hallmark. The radiotracer (d 3 )-[ 11 C]MODAG-001 has recently shown promise for visualization of α-synuclein pre-formed fibrils (α-PFF) in rodents. We here test the radiotracer in a pig model where proteins are intracerebrally injected immediately before scanning. Four pigs were injected in one hemisphere with 150 µg α-PFF, and in the other hemisphere, either 75 µg α-PFF or human brain homogenate from either dementia with Lewy bodies (DLB) or Alzheimer’s disease (AD) was injected. All pigs underwent one or two (d 3 )-[ 11 C]MODAG-001 PET scans, quantified with the non-invasive Logan graphical analysis using the occipital cortex as a reference region. Results: The α-PFF and AD homogenate injected brain regions had high uptake of (d 3 )-[ 11 C]MODAG-001 compared to the occipital cortex or cerebellum. BP ND values in 150 µg α-PFF injected regions was 0.78, and in the AD homogenate injected regions was 0.73. By contrast, the DLB homogenate injected region did not differ in uptake and clearance compared to the reference regions. The time-activity curves and BP ND values in the 150 µg and 75 µg injected region of α-PFFs show a dose-dependent effect, and the PET signal could be blocked by pretreatment with unlabeled MODAG-001. Conclusion: We find that both α-PFF and AD brain homogenates give rise to increased binding of (d 3 )-[ 11 C]MODAG-001 when injected into the pig brain. Despite its limited specificity for cerebral α-synuclein pathology, (d 3 )-[ 11 C]MODAG-001 shows promise as a lead tracer for future radiotracer development.